Impact of liver transplantation on familial amyloidotic polyneuropathy (FAP) patients' symptoms and complications

Amyloid

Volumn 10, Issue SUPPL. 1, 2003, Pages 77-83

  Suhr, Ole B ^a  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Amyloid neuropathy; Familial liver transplantation; Inborn errors of metabolism

Indexed keywords

AMYLOID P COMPONENT; PREALBUMIN; SERUM AMYLOID P;

AMINO ACID SUBSTITUTION; CARDIOMYOPATHY; CONFERENCE PAPER; FAMILIAL AMYLOID POLYNEUROPATHY; GENE MUTATION; HEART ARRHYTHMIA; HUMAN; HUMAN TISSUE; KIDNEY FUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; NERVE BIOPSY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SYMPTOMATOLOGY;

EID: 0242559060     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506129.2003.12088571     Document Type: Conference Paper

References (48)

1. Holmgren G, Steen L, Ekstedt J, Groth CG, Ericzon BG, Eriksson S, Andersen O, Karlberg I, Norden G, Nakazato M et al. (1991). Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 40, 242-246
2. Tawara S, Nakazato M, Kangawa K, Matsuo H and Araki S (1983). Identification of amyloid prealbumin variant in familial amyloidotic polyneuropathy (Japanese type). Biochem Biophys Res Commun 116, 880-888
3. Westermark P, Sletten K, Johansson B and Cornwell GG 3rd (1990). Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87, 2843-2845
4. Rydh A, Suhr O, Hietala SO, Ahlstrom KR, Pepys MB and Hawkins PN (1998). Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation. Eur J Nucl Med 25, 709-713
5. Nyhlin N, Anan I, El SM, Ando Y and Suhr OB (2002). Reduction of free radical activity in amyloid deposits following liver transplantation for familial amyloidotic polyneuropathy. J Intern Med 251, 136-141
6. Anan I, El-Salhy M, Nyhlin N and Suhr OB (2000). Liver transplantation restores endocrine cells in patients with familial amyloidotic polyneuropathy. Transplantation 70, 794-799
7. Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Plante V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H and Said G (2000). The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123, 1495-1504
8. Bergethon PR, Sabin TD, Lewis D, Simms RW, Cohen AS and Skinner M (1996). Improvement in the polyneuropathy associated with familial amyloid polyneuropathy after liver transplantation. Neurology 47, 944-951
9. de Carvalho M, Conceicao I, Bentes C and Luis ML (2002). Long-term quantitative evaluation of liver transplantation in familial amyloid polyneuropathy (Portuguese V30M). Amyloid: J Protein Folding Disord 9, 126-133
10. Holmgren G, Ericzon BG, Groth CG, Steen L, Suhr O, Andersen O, Wallin BG, Seymour A, Richardson S, Hawkins PN et al. (1993). Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 341, 1113-1116
11. Parrilla P, Ramirez P, Andreu LF, Bueno SF, Robles R, Miras M, Acosta F, Viader-Farre D, de Mingo P, Bermejo J, Garrido SF and Munar-Ques M (1997). Long-term results of liver transplantation in familial amyloidotic polyneuropathy type I. Transplantation 64, 646-649
12. Parrilla P, Ramirez P, Bueno FS, Robles R, Acosta F, Miras M, Pons JA, Andreu FL and Munar-Ques M (1995). Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Surg 82, 825-828
13. Suhr OB, Holmgren G, Steen L, Wikstrom L, Norden G, Friman S, Duraj FF, Groth CG and Ericzon BG (1995). Liver transplantation in familial amyloidotic polyneuropathy. Follow-up of the first 20 Swedish patients. Transplantation 60, 933-938
14. Takei Y, Ikeda S, Hashikura Y, Ikegami T and Kawasaki S (1999). Partial-liver transplantation to treat familial amyloid polyneuropathy: follow-up of 11 patients. Ann Intern Med 131, 592-595
15. Tashima K, Ando Y, Terazaki H, Yoshimatsu S, Suhr OB, Obayashi K, Yamashita T, Ando E, Uchino M and Ando M (1999). Outcome of liver transplantation for transthyretin amyloidosis: follow-up of Japanese familial amyloidotic polyneuropathy patients. J Neurol Sci 171, 19-23
16. Ikeda S, Takei Y, Yanagisawa N, Matsunami H, Hashikura Y, Ikegami T and Kawasaki S (1997). Peripheral nerves regenerated in familial amyloid polyneuropathy after liver transplantation. Ann Intern Med 127, 618-620
17. Garcia-Herola A, Prieto M, Pascual S, Berenguer M, Lopez-Viedma B, Mir J, Vilchez JJ and Berenguer J (1999). Progression of cardiomyopathy and neuropathy after liver transplantation in a patient with familial amyloidotic polyneuropathy caused by tyrosine-77 transthyretin variant. Liver Transpl Surg 5, 246-248
18. Stangou AJ, Booth DR, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Williams R, Pepys MB and Hawkins PN (1999). Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy. In Kyle RA, Gertz MA (eds.) 1999. Amyloid and Amyloidosis, pp. 330-332. (Carnforth, UK: Parthenon Publishing)
19. Pomfret EA, Lewis WD, Jenkins RL, Bergethon P, Dubrey SW, Reisinger J, Falk RH and Skinner M (1998). Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 65, 918-925
20. Suhr OB, Wiklund U, Ando Y, Ando E and Olofsson BO (1997). Impact of liver transplantation on autonomic neuropathy in familial amyloidotic polyneuropathy: an evaluation by spectral analysis of heart rate variability. J Intern Med 242, 225-229
21. Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, Uchino M and Ando M (1995). Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I [letter]. Lancet 345, 195-196
22. Owa M, Takei Y, Hashikura Y, Kawasaki S, Koyama M and Ikeda S (2001). Recurrent cerebral embolism in a familial amyloid polyneuropathy patient who received partial liver transplantation from a living donor. Intern Med 40, 259-264
23. Yazaki M, Tokuda T, Nakamura A, Higashikata T, Koyama J, Higuchi K, Harihara Y, Baba S, Kametani F and Ikeda S (2000). Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin. Biochem Biophys Res Commun 274, 702-706
24. Dubrey SW, Davidoff R, Skinner M, Bergethon P, Lewis D and Falk RH (1997). Progression of ventricular wall thickening after liver transplantation for familial amyloidosis. Transplantation 64, 74-80
25. Kruger M, Altland K, Linke RP, Maschek H, Ringe B, Oehler G, Pichlmayr R and Manns MP (1997). [Liver transplantation in familial amyloid polyneuropathy. Case report and review of the literature]. Internist (Berl) 38, 692-700
26. Golling M, Singer R, Weiss G, Mehrabi A, Zapletal C, Kraus T, Herfarth C and Klar E (2000). Sequential (domino) transplantation of the liver in a transthyretin-50 familial amyloid polyneuropathy. Special reference to cardiological diagnosis and complications. Langenbecks Arch Surg 385, 21-26
27. Stangou AJ, Hawkins PN, Heaton ND, Rela M, Monaghan M, Nihoyannopoulos P, O'Grady J, Pepys MB and Williams R (1998). Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: implications for amyloid fibrillogenesis. Transplantation 66, 229-233
28. Ramirez P, De Mingo P, Andreu F, Munar M, Hernandez Q, Munitiz V, Robles R, Sanchez-Bueno F and Parrilla P (2000). Long-term results of liver transplantation in four siblings from the same family with familial amyloidotic polyneuropathy type I TTR Ala-71. Transpl Int 13 Suppl 1, S171-173
29. Olofsson BO, Backman C, Karp K and Suhr OB (2002). Progression of cardiomyopathy after liver transplantation in patients with familial amyloidotic polyneuropathy, Portuguese type. Transplantation 73, 745-751
30. Anan I, El-Salhy M, Ando Y, Forsgren S, Nyhlin N, Terazaki H, Sakashita N and Suhr OB (1999). Colonic enteric nervous system in patients with familial amyloidotic neuropathy. Acta Neuropathol (Berl) 98, 48-54
31. Anan I, El-Salhy M, Ando Y, Terazaki H and Suhr OB (2001). Comparison of amyloid deposits and infiltration of enteric nervous system in the upper with those in the lower gastrointestinal tract in patients with familial amyloidotic polyneuropathy. Acta Neuropathol (Berl) 102, 227-232
32. Suhr O, Danielsson A and Steen L (1992). Bile acid malabsorption caused by gastrointestinal motility dysfunction? An investigation of gastrointestinal disturbances in familial amyloidosis with polyneuropathy. Scand J Gastroenterol 27, 201-207
33. Suhr O, Danielsson A, Rydh A, Nyhlin N, Hietala SO and Steen L (1996). Impact of gastrointestinal dysfunction on survival after liver transplantation for familial amyloidotic polyneuropathy. Dig Dis Sci 41, 1909-1914
34. Nyhlin N, Anan I, El-Salhy M, Ando Y and Suhr OB (1999). Endocrine cells in the upper gastrointestinal tract in relation to gastrointestinal dysfunction in patients with familial amyloidotic polyneuropathy. Amyloid: Int J Exp Clin Invest 6, 192-198
35. El-Salhy M, Suhr O, Stenling R, Wilander E and Grimelius L (1994). Impact of familial amyloid associated polyneuropathy on duodenal endocrine cells. Gut 35, 1413-1418
36. Lng K, Wikstr m L, Danielsson , Tashima K and Suhr OB (2000). Outcome of gastrointestinal complications after liver transplantation for familial amyloidotic polyneuropathy. Scand J Gastroenterol 35, 985-989
37. Lobato L, Beirao I, Guimaraes SM, Droz D, Guimaraes S, Grunfeld JP and Noel LH (1998). Familial amyloid polyneuropathy type I (Portuguese): distribution and characterization of renal amyloid deposits. Am J Kidney Dis 31, 940-946
38. Carvalho MJ, Lobato L, Ventura A, Beirao I, Rocha G, Seca R, Miranda HP, Silvestre F, Pereira MC and Guimaraes S (2000). Remission of proteinuria following liver transplantation for familial amyloid polyneuropathy TTR met30. Transplant Proc 32, 2664-2666
39. Munar-Ques M, Salva-Ladaria L, Mulet-Perera P, Sole M, Lopez-Andreu FR and Saraiva MJ (2000). Vitreous amyloidosis after liver transplantation in patients with familial amyloid polyneuropathy: ocular synthesis of mutant transthyretin. Amyloid: Int J Exp Clin Invest 7, 266-269
40. Ando Y, Ando E, Tanaka Y, Yamashita T, Tashima K, Suga M, Uchino M, Negi A and Ando M (1996). De novo amyloid synthesis in ocular tissue in familial amyloidotic polyneuropathy after liver transplantation [letter]. Transplantation 62, 1037-1038
41. Jons n E, Suhr O, Athlin E and Wikstr m L (1996). Quality of life after liver transplantation in patients with familial amyloidotic polyneuropathy. Amyloid: Int J Exp Clin Invest 3, 124-129
42. Lopes A, Branco M, Coelho T, Sousa A and Caetano-Pereira M (1999). Psycho-social and familial impact of liver transplant in patients with familial amyloid polyneuropathy (FAP). Presented at The 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, June, p. 68
43. Libbey C, La Valley M, Murakami A, Katz S, Lewis D and Skinner M (1999). Familial amyloidosis, 7 years clinical experience and liver transplant quality of life assessments. Presented at The 4th International Symposium on Familial Amyloidotic Polyneuropathy and Other Transthyretin Related Disorders & the 3rd International Workshop on Liver Transplantation in Familial Amyloid Polyneuropathy, June, p. 47
44. Jonsen E, Suhr OB, Tashima K and Athlin E (2001). Early liver transplantation is essential for familial amyloidotic polyneuropathy patients' quality of life. Amyloid: Int J Exp Clin Invest 8, 52-57
45. Alves M, Conceicao I and Luis ML (1997). Neurophysiological evaluation of sexual dysfunction in familial amyloidotic polyneuropathy - Portuguese type. Acta Neurol Scand 96, 163-166
46. Ando Y, Yi S, Nakagawa T, Ikegawa S, Hirota M, Miyazaki A and Araki S (1991). Disturbed metabolism of glucose and related hormones in familial amyloidotic polyneuropathy: hypersensitivities of the autonomic nervous system and therapeutic prevention. J Auton Nerv Syst 35, 63-70
47. Olofsson BO, Grankvist K, Boman K, Forsberg K, Lafvas I and Lithner F (1989). Assessment of thyroid and adrenal function in patients with familial amyloidotic polyneuropathy. J Intern Med 225, 337-341
48. Olofsson BO, Grankvist K, Olsson T, Boman K, Forsberg K, Lafvas I and Lithner F (1991). Assessment of hypothalamic-pituitary function in patients with familial amyloidotic polyneuropathy. J Intern Med 229, 55-59